QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 专题：武汉大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 14 作者:  Ni, Li-Hua;  Tang, Ri-Ning;  Yuan, Cheng;  Song, Kai-Yun;  Wang, Li-Ting 收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05 Chronic kidney disease (CKD)  parathyroid hormone (PTH)  osteoporosis  endothelial cells (ECs)  adipocytes   Efficacy and safety of cinacalcet and active vitamin D in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease: a network meta-analysis 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 14 作者:  Ni, Li-Hua;  Yuan, Cheng;  Song, Kai-Yun;  Wang, Xiao-Chen;  Chen, Si-Jie 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05 Secondary hyperparathyroidism (SHPT)  chronic kidney disease (CKD)  cinacalcet  active vitamin D  network meta-analysis (NMA)   The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease 期刊论文 INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 卷号: 43 作者:  Yu, Gang;  Bai, Zhiming;  Chen, Zhiyuan;  Chen, Hui;  Wang, Guoren 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 CKD  Renal inflammation  Ozone therapy  NLRP3  IL-1 beta   Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China 期刊论文 BMC NEPHROLOGY, 2013, 卷号: 14 作者:  Xu, Jing;  Zhang, Yi-Xiang;  Yu, Xue-Qing;  Liu, Zhi-Hong;  Wang, Li-Ning 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Lanthanum carbonate  Hyperphosphatemia  Chronic kidney disease 5D  Hemodialysis  Continuous ambulatory peritoneal dialysis (CAPD)